Variant report
Variant | rs4506429 |
---|---|
Chromosome Location | chr1:180106573-180106574 |
allele | A/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:180104470..180106814-chr1:180110099..180112797,3 | K562 | blood: | |
2 | chr1:180105408..180107246-chr1:180123861..180125610,2 | K562 | blood: | |
3 | chr1:180098705..180101372-chr1:180105512..180107387,2 | MCF-7 | breast: | |
4 | chr1:180104990..180107036-chr1:180115597..180118209,2 | K562 | blood: | |
5 | chr1:180105036..180107165-chr1:180200973..180202930,2 | MCF-7 | breast: | |
6 | chr1:180103401..180107232-chr1:180135881..180138747,3 | MCF-7 | breast: | |
7 | chr1:180106112..180112838-chr1:180122179..180128333,6 | MCF-7 | breast: | |
8 | chr1:180103740..180108161-chr1:180108399..180112441,6 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000116260 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10753206 | 0.92[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.90[AMR][1000 genomes];0.89[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs10798729 | 0.81[CEU][hapmap];0.85[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs10798730 | 0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10798732 | 1.00[CEU][hapmap];0.88[CHB][hapmap];0.93[JPT][hapmap];0.93[AMR][1000 genomes];0.93[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10913917 | 0.89[CEU][hapmap] |
rs10913927 | 0.88[CEU][hapmap];0.83[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs10913931 | 0.96[AMR][1000 genomes];0.96[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs12027335 | 0.86[AMR][1000 genomes];0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs12040314 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[AMR][1000 genomes];0.96[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs12040376 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[AMR][1000 genomes];0.96[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs12080763 | 0.93[JPT][hapmap];0.87[ASN][1000 genomes] |
rs2477112 | 0.89[CEU][hapmap] |
rs2477116 | 0.81[AMR][1000 genomes] |
rs2477118 | 0.88[CEU][hapmap] |
rs2501607 | 0.88[CEU][hapmap] |
rs2501611 | 0.89[CEU][hapmap] |
rs2501613 | 0.88[CEU][hapmap] |
rs2501615 | 0.87[CEU][hapmap] |
rs2501617 | 0.81[CEU][hapmap] |
rs2762859 | 0.88[CEU][hapmap] |
rs3767200 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs3767202 | 0.83[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs3818999 | 0.84[CEU][hapmap];0.80[AMR][1000 genomes];0.85[EUR][1000 genomes] |
rs3930305 | 0.88[CEU][hapmap];0.85[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs4076449 | 0.89[CEU][hapmap] |
rs4147169 | 0.83[AMR][1000 genomes];0.85[EUR][1000 genomes] |
rs4256775 | 0.89[CEU][hapmap];0.81[EUR][1000 genomes] |
rs4336810 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.88[AMR][1000 genomes];0.96[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs4651057 | 0.88[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs4652462 | 0.81[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs4652463 | 0.82[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs4652465 | 0.89[CEU][hapmap];0.86[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs4652471 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[AMR][1000 genomes];0.96[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs4652472 | 0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs4652473 | 0.95[AMR][1000 genomes];0.96[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs4652475 | 0.94[AFR][1000 genomes];0.97[AMR][1000 genomes];0.93[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs483307 | 0.89[CEU][hapmap] |
rs510209 | 0.89[CEU][hapmap] |
rs528350 | 0.81[CEU][hapmap] |
rs60905477 | 0.81[ASN][1000 genomes] |
rs6425603 | 0.88[CEU][hapmap];0.81[EUR][1000 genomes] |
rs6425609 | 0.92[CEU][hapmap];0.82[CHB][hapmap];0.93[JPT][hapmap];0.86[AMR][1000 genomes];0.88[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6657347 | 0.88[CEU][hapmap];0.82[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs6691060 | 0.94[CHB][hapmap];1.00[JPT][hapmap];0.93[YRI][hapmap];1.00[AFR][1000 genomes];0.99[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs6691435 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[YRI][hapmap];0.98[AFR][1000 genomes];0.99[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7525385 | 0.85[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs7528811 | 0.81[CEU][hapmap];0.83[CHB][hapmap];0.82[ASN][1000 genomes] |
rs7551181 | 1.00[CEU][hapmap];0.86[CHB][hapmap];0.93[JPT][hapmap];0.93[AMR][1000 genomes];0.92[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs7551902 | 0.81[ASN][1000 genomes] |
rs9286932 | 0.88[CEU][hapmap];0.81[EUR][1000 genomes] |
rs9425481 | 0.85[EUR][1000 genomes] |
rs9425482 | 0.85[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs9425483 | 0.93[JPT][hapmap];0.89[ASN][1000 genomes] |
rs9425485 | 1.00[CEU][hapmap];0.88[CHB][hapmap];0.93[JPT][hapmap];0.93[AMR][1000 genomes];0.93[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs9425486 | 0.95[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs9425489 | 0.96[AMR][1000 genomes];0.96[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs9425849 | 0.89[CEU][hapmap];0.81[AMR][1000 genomes] |
rs9425854 | 0.88[CEU][hapmap];0.81[EUR][1000 genomes] |
rs9425855 | 0.81[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs9425856 | 0.83[EUR][1000 genomes] |
rs9425860 | 0.85[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs9425861 | 0.84[CEU][hapmap];0.85[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs9425863 | 0.96[AMR][1000 genomes];0.96[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs9425866 | 0.88[AFR][1000 genomes];0.93[AMR][1000 genomes];0.96[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs9425868 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv429936 | chr1:179790343-180214343 | Active TSS Strong transcription Flanking Active TSS Weak transcription Enhancers Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 72 gene(s) | inside rSNPs | diseases |
2 | nsv1003739 | chr1:180027760-180483292 | Enhancers ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh Strong transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 67 gene(s) | inside rSNPs | diseases |
3 | nsv535217 | chr1:180027760-180483292 | Enhancers Active TSS Flanking Active TSS Weak transcription ZNF genes & repeats Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 67 gene(s) | inside rSNPs | diseases |
4 | nsv1012558 | chr1:180027960-180217613 | Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Strong transcription Active TSS Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
5 | nsv535218 | chr1:180027960-180217613 | Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
6 | nsv497930 | chr1:180031321-180220723 | Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Active TSS Genic enhancers Enhancers Bivalent Enhancer Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
7 | nsv533073 | chr1:180031328-180217612 | Strong transcription Active TSS Enhancers Flanking Active TSS Genic enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
8 | nsv916937 | chr1:180031328-180220685 | Strong transcription Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:180104200-180107000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
2 | chr1:180105800-180107000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
3 | chr1:180105800-180110800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr1:180106000-180107200 | Enhancers | HUVEC | blood vessel |